Clinical data | |
---|---|
Trade names | Benfuran, Bentos, Betaclar, Glauconex |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C16H21NO4 |
Molar mass | 291.347 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
NY (what is this?) (verify) |
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma. It also acts as a β adrenoreceptor partial agonist. Befunolol was introduced in Japan in 1983 by Kakenyaku Kako Co. under the trade name Bentos.
Drugs used for glaucoma preparations and miosis (S01E) | |||||||
---|---|---|---|---|---|---|---|
Sympathomimetics | |||||||
Parasympathomimetics |
| ||||||
Carbonic anhydrase inhibitors/ (sulfonamides) | |||||||
Beta blocking agents | |||||||
Prostaglandin analogues (F2α) | |||||||
Other agents |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |